Mexico authorizes remdesivir to treat COVID

Published March 13, 2021, 11:08 AM
Mexico on Friday approved the anti-viral drug remdesivir for emergency use treating COVID-19 patients in the Latin American country, one of the worst hit by the pandemic.
In this file photo taken on April 08, 2020, one vial of the drug Remdesivir lies during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany, amidst the new coronavirus COVID-19 pandemic.
(Photo by Ulrich Perrey / POOL / AFP / MANILA BULLETIN)
Regulatory agency Cofepris said it had authorized the medicine for use exclusively by hospitals and specialist doctors during the early stages of the illness.

Related Keywords

Mexico , Germany , Eppendorf , Nordrhein Westfalen , Japan , Hamburg , United States , Canada , American , , University Hospital Eppendorf , A World Health , European Commission , Latin American , Ulrich Perrey , World Health Organization Backed , மெக்ஸிகோ , ஜெர்மனி , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , ஜப்பான் , ஹாம்பர்க் , ஒன்றுபட்டது மாநிலங்களில் , கனடா , அமெரிக்கன் , ஐரோப்பிய தரகு , லத்தீன் அமெரிக்கன் ,